Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP)
- 20 August 2015
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 39 (11), 1166-1171
- https://doi.org/10.1016/j.leukres.2015.08.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- How I treat the older patient with acute myeloid leukemiaBlood, 2015
- Acute myeloid leukemia in the elderly: do we know who should be treated and how?Leukemia & Lymphoma, 2013
- Challenges in Treating Older Patients with Acute Myeloid LeukemiaJournal of Oncology, 2010
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryBlood, 2009
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsBlood, 2009
- Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative GroupJournal of Clinical Oncology, 2009
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaHaematologica, 2008
- Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older PatientsJournal of Clinical Oncology, 2007
- Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trialBlood, 2001
- Acute Myeloid LeukemiaThe New England Journal of Medicine, 1999